Sec Form 3 Filing - Eisenberg Moshe @ CAMTEK LTD - 2026-04-13

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Eisenberg Moshe 2. Issuer Name and Ticker or Trading Symbol CAMTEK LTD [ CAMT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) PO BOX 482, 7 HAASIF ST. 3. Date of Earliest Transaction (MM/DD/YY) 04/13/2026 (Street) KFAR HESS 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Ordinary Shares 1,613 ( 1 ) D Ordinary Shares 2,782 ( 2 ) D Ordinary Shares 3,060 ( 3 ) D Ordinary Shares 3,921 ( 4 ) D Ordinary Shares 2,614 ( 5 ) D Ordinary Shares 4,600 ( 6 ) D Ordinary Shares 2,053 ( 7 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Eisenberg Moshe PO BOX 482 7 HAASIF ST. KFAR HESS Chief Financial Officer Signatures Moshe Eisenberg by: Oppenheimer Israel, as Attorney-in-fact 04/13/2026 Signature of Reporting Person Date

Explanation of Responses:

( 1 )These shares were issued upon vesting of previously granted performance stock units or restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Camtek Ltd. (the "Company"). ( 2 )The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest 25% on the first vesting date (01/16/2024) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. ( 3 )The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest in four equal annual installments (25% per year) commencing on 02/15/2024, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. ( 4 )The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The units vest 25% on the first vesting vate (04/01/2025) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. ( 5 )The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest in four equal annual installments (25% per year) commencing on 04/01/2025, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. ( 6 )The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest 25% on the first vesting date (03/18/2026) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. ( 7 )The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs vest 25% on the first vesting date (03/30/2027) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

Remarks: This Form 3 has been filed after March 18, 2026 but prior to April 20, 2026 in reliance on the temporary relief made available to the directors and officers of certain foreign private issuers by the Staff of the Securities and Exchange Commission in its no-action letter dated March 13, 2026.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.